SCHEMBL19960253

SCHEMBL19960253

S=P(c1ccccc1)(c1ccccc1)c1ccc2cc3c(nc2c1)c1ccccc1n1c2ccccc2nc31

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.42
MAPT P10636 7/20 0.42
TP53 P04637 2/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 2/20 0.42
HPGD P15428 6/20 0.41
ALDH1A1 P00352 6/20 0.41
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
CASP1 P29466 4/20 0.36
CASP7 P55210 4/20 0.36
TSHR P16473 4/20 0.36
MAPK1 P28482 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
NPC1 O15118 2/20 0.36
USP2 O75604 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960067 0.92 KDM4E (0.39) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19965974 0.91 MAPT (0.39) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19960257 0.91 KDM4E (0.42) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19960252 0.89 KDM4E (0.40) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19965990 0.88 KDM4E (0.39) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19960123 0.87 KDM4E (0.41) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19966011 0.83 KDM4E (0.44) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19960237 0.83 KDM4E (0.44) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL19965969 0.82 KDM4E (0.43) KDM4EMAPTTP53HSD17B10LMNA
SCHEMBL17403792 0.82 KDM4E (0.47) KDM4EMAPTTP53HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885TP53 3534/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885MAPT 1310/4885TP53 3534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.